Agfa-Gevaert Q2 2025 Results: Strong HealthCare IT Performance, Stable Digital Print & Chemicals, Further Decline in Medical Film
ByAinvest
Wednesday, Aug 27, 2025 1:47 am ET1min read
Agfa-Gevaert Groep reported a strong performance in HealthCare IT and stable performance in Digital Print & Chemicals, but the continued decline in medical film sales offset these gains. Adjusted EBITDA decreased to €13m, while net income was €30m, driven by a positive impact from a final ruling in the AgfaPhoto case. The company signed a new, 3-year revolving credit facility of €180m.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet